Same Indication

Rosuvastatin vs Yttrium Y 90 Ibritumomab Tiuxetan

## Rosuvastatin vs Yttrium Y 90 Ibritumomab Tiuxetan: Overview

This comparison examines the pharmacological differences between **Rosuvastatin** and **Yttrium Y 90 Ibritumomab Tiuxetan**.

## Mechanism of Action

**Rosuvastatin**: Competitive inhibitor of HMG-CoA reductase.

## Pharmacokinetics

**Half-life**: Rosuvastatin — 19 hours; Yttrium Y 90 Ibritumomab Tiuxetan — N/A.

## Chemical Properties

**Molecular Formula**: Rosuvastatin — C22H28FN3O6S; Yttrium Y 90 Ibritumomab Tiuxetan — N/A.

**Molecular Weight**: Rosuvastatin — 481.5390 g/mol; Yttrium Y 90 Ibritumomab Tiuxetan — N/A.

**Type**: Rosuvastatin — Small molecule; Yttrium Y 90 Ibritumomab Tiuxetan — Antibody.